Welcome to CDC Stacks | Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer? - 39146 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?
Filetype[PDF - 174.60 KB]


Details:
  • Pubmed ID:
    26372482
  • Pubmed Central ID:
    PMC4703472
  • Description:
    Objective

    Squamous cell carcinoma (SCC) of the rectum is rare, but as with anal cancer, risk may be increased among immunosuppressed individuals. We assessed risk of rectal SCC in HIV-infected people.

    Design

    Population-based registry

    Methods

    We utilized the HIV/AIDS Cancer Match, a linkage of US HIV and cancer registries (1991–2010), to ascertain cases of anal SCC, rectal SCC, rectal non-SCC, and colon non-SCC. We compared risk in HIV-infected persons to the general population using standardized incidence ratios (SIRs) and evaluated risk factors using Poisson regression. We reviewed cancer registry case notes to confirm site and histology for a subset of cases.

    Results

    HIV-infected persons had an excess risk of rectal SCC compared to the general population (SIR=28.9; 95%CI 23.2–35.6), similar to the increase for anal SCC (SIR=37.3). Excess rectal SCC risk was most pronounced among HIV-infected men who have sex with men (MSM, SIR=61.2). Risk was not elevated for rectal non-SCC (SIR=0.88) or colon non-SCC (SIR=0.63). Individuals diagnosed with AIDS had higher rectal SCC rates than those with HIV-only (incidence rate ratio=1.86; 95%CI 1.04–3.31). Based on available information, one-third of rectal SCCs were determined to be misclassified anal cancer.

    Conclusions

    HIV-infected individuals, especially with advanced immunosuppression, appear to have substantially elevated risk for rectal SCC. As for anal SCC, rectal SCC risk was highest in MSM, pointing to involvement of a sexually transmitted infection such as human papillomavirus. Site misclassification was present, and detailed information on tumor location is needed to prove that rectal SCC is a distinct entity.

  • Document Type:
  • Collection(s):
  • Funding:
    261201000024C/PHS HHS/United States
    261201300021I/PHS HHS/United States
    5U58/DP003931-02/DP/NCCDPHP CDC HHS/United States
    5U58DP000824-04/DP/NCCDPHP CDC HHS/United States
    5U58DP003875-01/DP/NCCDPHP CDC HHS/United States
    5U58DP003921-03/DP/NCCDPHP CDC HHS/United States
    5U62PS001005-05/PS/NCHHSTP CDC HHS/United States
    N01-PC-2013-00021/PC/NCI NIH HHS/United States
    U58DP000848-04/DP/NCCDPHP CDC HHS/United States
    U62PS004001-2/PS/NCHHSTP CDC HHS/United States
    U62PS004011-02/PS/NCHHSTP CDC HHS/United States
    Z99 CA999999/Intramural NIH HHS/United States
No Related Documents.
You May Also Like: